Italfarmaco S.p.A.
Privately held: no public share price
Assets
(1 total)
1Total Assets
1Approved
0Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Approved | HDACSmall molecule | Duchenne Muscular DystrophyPolycythemia Vera |
Upcoming events
(4 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2026 (1)
December 2026 (1)
Est. primary completion 2026-12 · NCT01761968 · CT.gov ↗
What to watch
2028 (1)
February 2028 (1)
Est. primary completion 2028-02 · NCT05933057 · CT.gov ↗
What to watch
Financial reports
No financial reports recorded.